+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oligonucleotide Synthesis Market Size, Share & Trends Analysis Report By Product (Column-based, Array-based, Services), By Application (PCR Primer, FISH), By End-user, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 150 Pages
  • May 2023
  • Region: Global
  • Grand View Research
  • ID: 4668008
Description Jump to:

Quick Summary:

In an ever-evolving business landscape, understanding industry-specific trends, emergent technologies, and market dynamics is paramount to maintain a competitive advantage. The Global Oligonucleotide Synthesis Market Report offers this critical insight to enhance your business acumen and expedite strategic decision-making. It provides comprehensive market analysis, highlighting the escalating use of oligonucleotide synthesis in diverse fields ranging from human health management to molecular diagnostics and therapeutics.

The increasing prevalence of chronic diseases is intensifying the demand for novel therapeutics and targeted drugs. As a result, there's a surge in R&D investments by prominent drug discovery and pharmaceutical manufacturing companies. This report also emphasizes the preference towards oligonucleotides by pharmaceutical and biotechnology companies due to their cost-effectiveness and rational drug design. It delves into the growing demand for cancer-related therapies and how this has fueled the exploration of custom oligonucleotide synthesis in cancer research.

Stay ahead of the curve and lead with clarity by leveraging our report's invaluable, in-depth analysis. Make informed, strategic decisions that will strengthen your presence in the oligonucleotide synthesis market.

The global oligonucleotide synthesis market size is expected to reach USD 8.83 billion by 2030. The market is expected to expand at a CAGR of 13.22% from 2023 to 2030. The increasing usage of oligonucleotide synthesis in several field such as human health management, molecular diagnostics, and therapeutics have boosted the demand for this product thereby contributing to the market’s revenue growth.

Oligonucleotides are most widely used as PCR primers. Rapid integration of PCR in most molecular biology techniques resulted in large-scale use and higher penetration since the introduction of PCR. This can be attributed to the large revenue share of oligonucleotide synthesis for production of PCR primers. PCR primers are short and a small-scale synthesis is sufficient for a large number of reactions. The large-scale synthesis is used in structural experiments or therapeutic applications such as anti-sense therapeutics and gene therapy. Limited success in clinical trials for oligonucleotide therapeutics and gene therapy restricts the growth of antisense oligonucleotide.

Rising prevalence of chronic diseases such as various types of cancers, neurodegenerative diseases, and cardiovascular conditions has increased the need for novel therapeutics and target drugs. Major drug discovery and pharmaceutical manufacturing companies have significantly increased their investments in R&D. However, the high cost associated with drug discovery processes and prolonged-time required is a major concern for most developers.

Furthermore, the demand for alternative tools and technologies that accelerate processing steps, eliminate errors, and meet standard regulatory conditions has increased. Oligonucleotides are found to be more effective than conventional small molecules. They are more preferred by pharmaceutical and biotechnology companies due to their low development costs and rational drug design. Thus, a year-over-year increase in investment in drug discovery and pharmaceutical R&D coupled with the adoption of oligonucleotide as therapeutics is anticipated to drive the market.

Furthermore, the increasing demand for cancer-related therapies that could detect the presence of malignant cell has further impacted the market positively. Moreover, this has resulted in an increase in investments aiding to explore the potential application of custom oligonucleotide synthesis in cancer research.

Oligonucleotide Synthesis Market Report Highlights

  • By product type, the reagents segment is anticipated to witness significant growth in the coming years as reagents have recurring demand and usage in the oligonucleotide synthesis process. A number of reagents are required for different steps involved in the synthesis
  • The PCR primers application segment captured the largest market share in 2022 owing to its potential usage in fluorescent detection and target identification with higher penetration of products in this segment
  • By end user, the academic research institutes segment dominated the market in 2022 owing to significant genomic research being conducted by universities and academic research institutes either in collaboration with private investors or with government support
  • North America dominated the global market in 2022, owing to huge investments in genetic research and development field and effective regulatory policies encouraging the adoption of oligonucleotide synthesis for gene-based research in the region
  • The Asia Pacific is expected to grow at a significant pace in the future owing to increasing awareness among people of this region and increasing number of key market players


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Oligonucleotide Synthesis Market

What is the estimated value of the Global Oligonucleotide Synthesis Market?

The Global Oligonucleotide Synthesis Market was estimated to be valued at $3.29 Billion in 2022.

What is the growth rate of the Global Oligonucleotide Synthesis Market?

The growth rate of the Global Oligonucleotide Synthesis Market is 13.2%, with an estimated value of $8.83 Billion by 2030.

What is the forecasted size of the Global Oligonucleotide Synthesis Market?

The Global Oligonucleotide Synthesis Market is estimated to be worth $8.83 Billion by 2030.

Who are the key companies in the Global Oligonucleotide Synthesis Market?

Key companies in the Global Oligonucleotide Synthesis Market include Thermo Fisher Scientific, Inc., Merck & Co. Inc, PerkinElmer Inc., Agilent Technologies, Inc, Bio, synthesis, Inc., Kaneka Eurogentec S.A, Integrated DNA Technologies, Inc., BioAutomation (BIOSEARCH TECHNOLOGIES) and Biolegio.
Report AttributeDetails
No. of Pages150
PublishedMay 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 3.29 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.83 Billion
Compound Annual Growth Rate13.2%
Regions CoveredGlobal
No. of Companies Mentioned10

Table of Contents

Chapter 1. Methodology and Scope
1.1. Information Procurement
1.2. Information Or Data Analysis
1.3. Market Scope & Segment Definition
1.4. Market Model
1.4.1. Market Study, By Company Market Share
1.4.2. Regional Analysis
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Strong Pipeline of Oligonucleotide Therapeutics in Clinical Trials
3.2.1.2. Changing Regulatory Environments For Genetic Research And Its Applications In Healthcare
3.2.1.3. High R & D Spending of Pharmaceutical - Biotechnology Companies
3.2.1.4. Increased Public-Private Spending on Genomics
3.2.1.5. Technological Advancements in Gene Editing Technologies
3.2.2. Market Restraint Analysis
3.2.2.1. Need For Advanced Oligo Synthesis Solutions
3.2.2.2. High Cost Associated with Genomics Research
3.2.2.3. Lack Of Skilled Professionals And Research Support In Undeveloped Countries
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Oligonucleotide Synthesis Market: Product Movement Analysis
4.2. Oligonucleotides
4.2.1. Oligonucleotides Market, 2018 - 2030 (USD Million)
4.2.2. Oligonucleotides, By Product Type
4.2.2.1 Column-Based Oligos
4.2.2.1.1 Global Column-Based Oligos Market, 2018 - 2030 (USD Million)
4.2.2.2 Array-Based Oligos
4.2.2.2.1 Global Array-Based Oligos Market, 2018 - 2030 (USD Million)
4.2.3. Oligonucleotides, By Nucleic Acid Type
4.2.3.1 DNA Oligos
4.2.3.1.1 Global DNA Oligo Market, 2018 - 2030 (USD Million)
4.2.3.2 RNA Oligos
4.2.3.2.1 Global RNA Oligo Market, 2018 - 2030 (USD Million)
4.3. Equipment/ Synthesizers
4.3.1. Global Oligonucleotide Synthesis Equipment Market, 2018 - 2030 (USD Million)
4.4. Reagents
4.4.1. Global Oligonucleotide Synthesis Reagents Market, 2018 - 2030 (USD Million)
4.5. Services
4.5.1. Global Oligonucleotide Services Market, 2018 - 2030 (USD Million)
4.5.2. Oligo Synthesis
4.5.2.1. Global Oligo Synthesis Services Market, 2018 - 2030 (USD Million)
4.5.2.2. 25 nmol
4.5.2.2.1. Global 25 Nmol Oligo Synthesis Services Market, 2018 - 2030 (USD Million)
4.5.2.3. 50 nmol
4.5.2.3.1. Global 50 Nmol Oligo Synthesis Services Market, 2018 - 2030 (USD Million)
4.5.2.4. 200 nmol
4.5.2.4.1. Global 200 Nmol Oligo Synthesis Services Market, 2018 - 2030 (USD Million)
4.5.2.5. 1,000 nmol
4.5.2.5.1. Global 1,000 nmol Oligo Synthesis Services Market, 2018 - 2030 (USD Million)
4.5.2.6. 10,000 nmol
4.5.2.6.1. Global 10,000 nmol Oligo Synthesis Services Market, 2018 - 2030 (USD Million)
4.5.3. Purification
4.5.3.1. Global Oligonucleotide Purification Services Market, 2018 - 2030 (USD Million)
4.5.4. Modification
4.5.4.1. Global Oligonucleotide Modification Services Market, 2018 - 2030 (USD Million)
Chapter 5. Application Business Analysis
5.1. Oligonucleotide Synthesis Market: Application Movement Analysis
5.2. PCR Primers
5.2.1. PCR Primers Market, 2018 - 2030 (USD Million)
5.3. PCR Assays and Panels
5.3.1. PCR Assays and Panels Market, 2018 - 2030 (USD Million)
5.4. Sequencing
5.4.1. Sequencing Market, 2018 - 2030 (USD Million)
5.5. DNA Microarrays
5.5.1. DNA Microarrays Market, 2018 - 2030 (USD Million)
5.6. Fluorescence In Situ Hybridization (FISH)
5.6.1. Fluorescence In Situ Hybridization (FISH) Market, 2018 - 2030 (USD Million)
5.7. Antisense Oligonucleotides
5.7.1. Antisense Oligonucleotides Market, 2018 - 2030 (USD Million)
5.8. Other Applications
5.8.1. Other Applications Market, 2018 - 2030 (USD Million)
Chapter 6. End-User Business Analysis
6.1. Oligonucleotide Synthesis Market: End-User Movement Analysis
6.2. Academic and Research Institutes
6.2.1. Academic and Research Institutes Market, 2018 - 2030 (USD Million)
6.3. Pharmaceutical & Biotechnology Companies
6.3.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
6.4. Diagnostic Laboratories
6.4.1. Diagnostic Laboratories Market, 2018 - 2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Oligonucleotide Synthesis Market Share By Region, 2022 & 2030
7.2. North America
7.2.1. SWOT Analysis
7.2.2. North America Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.2.3. U.S.
7.2.3.1. Key Country Dynamics
7.2.3.2. Regulatory Framework
7.2.3.3. Competitive Scenario
7.2.3.4. U.S. Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.2.4. Canada
7.2.4.1. Key Country Dynamics
7.2.4.2. Regulatory Framework
7.2.4.3. Competitive Scenario
7.2.4.4. Canada Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. SWOT Analysis
7.3.2. Europe Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.3.3. UK
7.3.3.1. Key Country Dynamics
7.3.3.2. Regulatory Framework
7.3.3.3. Competitive Scenario
7.3.3.4. UK Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.3.4. Germany
7.3.4.1. Key Country Dynamics
7.3.4.2. Regulatory Framework
7.3.4.3. Competitive Scenario
7.3.4.4. Germany Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.3.5. France
7.3.5.1. Key Country Dynamics
7.3.5.2. Regulatory Framework
7.3.5.3. Competitive Scenario
7.3.5.4. France Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.3.6. Italy
7.3.6.1. Key Country Dynamics
7.3.6.2. Regulatory Framework
7.3.6.3. Competitive Scenario
7.3.6.4. Italy Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.3.7. Spain
7.3.7.1. Key Country Dynamics
7.3.7.2. Regulatory Framework
7.3.7.3. Competitive Scenario
7.3.7.4. Spain Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.3.8. Denmark
7.3.8.1. Key Country Dynamics
7.3.8.2. Regulatory Framework
7.3.8.3. Competitive Scenario
7.3.8.4. Denmark Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.3.9. Sweden
7.3.9.1. Key Country Dynamics
7.3.9.2. Regulatory Framework
7.3.9.3. Competitive Scenario
7.3.9.4. Sweden Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.3.10. Norway
7.3.10.1. Key Country Dynamics
7.3.10.2. Regulatory Framework
7.3.10.3. Competitive Scenario
7.3.10.4. Norway Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. SWOT Analysis
7.4.2. Asia Pacific Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Key Country Dynamics
7.4.3.2. Regulatory Framework
7.4.3.3. Competitive Scenario
7.4.3.4. Japan Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.4.4. China
7.4.4.1. Key Country Dynamics
7.4.4.2. Regulatory Framework
7.4.4.3. Competitive Scenario
7.4.4.4. China Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.4.5. India
7.4.5.1. Key Country Dynamics
7.4.5.2. Regulatory Framework
7.4.5.3. Competitive Scenario
7.4.5.4. India Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Key Country Dynamics
7.4.6.2. Regulatory Framework
7.4.6.3. Competitive Scenario
7.4.6.4. Australia Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Key Country Dynamics
7.4.7.2. Regulatory Framework
7.4.7.3. Competitive Scenario
7.4.7.4. Thailand Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.4.8. South Korea
7.4.8.1. Key Country Dynamics
7.4.8.2. Regulatory Framework
7.4.8.3. Competitive Scenario
7.4.8.4. South Korea Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. SWOT Analysis
7.5.2. Latin America Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.5.3. Brazil
7.5.3.1. Key Country Dynamics
7.5.3.2. Regulatory Framework
7.5.3.3. Competitive Scenario
7.5.3.4. Brazil Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.5.4. Mexico
7.5.4.1. Key Country Dynamics
7.5.4.2. Regulatory Framework
7.5.4.3. Competitive Scenario
7.5.4.4. Mexico Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.5.5. Argentina
7.5.5.1. Key Country Dynamics
7.5.5.2. Regulatory Framework
7.5.5.3. Competitive Scenario
7.5.5.4. Argentina Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.6. MEA
7.6.1. SWOT Analysis
7.6.2. MEA Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.6.3. South Africa
7.6.3.1. Key Country Dynamics
7.6.3.2. Regulatory Framework
7.6.3.3. Competitive Scenario
7.6.3.4. South Africa Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.6.4. Saudi Arabia
7.6.4.1. Key Country Dynamics
7.6.4.2. Regulatory Framework
7.6.4.3. Competitive Scenario
7.6.4.4. Saudi Arabia Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.6.5. UAE
7.6.5.1. Key Country Dynamics
7.6.5.2. Regulatory Framework
7.6.5.3. Competitive Scenario
7.6.5.4. UAE Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
7.6.6. Kuwait
7.6.6.1. Key Country Dynamics
7.6.6.2. Regulatory Framework
7.6.6.3. Competitive Scenario
7.6.6.4. Kuwait Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Share Analysis, 2022
8.4. Company Profiles/Listing
8.4.1. Thermo Fisher Scientific, Inc.
8.4.1.1. Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Merck & Co. Inc
8.4.2.1. Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. PerkinElmer Inc.
8.4.3.1. Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Agilent Technologies, Inc
8.4.4.1. Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Bio-synthesis, Inc.
8.4.5.1. Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Kaneka Eurogentec S.A
8.4.6.1. Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Integrated DNA Technologies, Inc.
8.4.7.1. Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. BioAutomation (BIOSEARCH TECHNOLOGIES)
8.4.8.1. Overview
8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Biolegio
8.4.9.1. Overview
8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Twist Bioscience
8.4.10.1. Overview
8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of abbreviations
Table 2 Global oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 3 Global oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 4 Global oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 5 Global oligonucleotide synthesis market, by region, 2018 - 2030 (USD Million)
Table 6 North America oligonucleotide synthesis market, by country, 2018 - 2030 (USD Million)
Table 7 North America oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 8 North America oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 9 North America oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 10 U.S. oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 11 U.S. oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 12 U.S. oligonucleotide synthesis Market, by end user, 2018 - 2030 (USD Million)
Table 13 Canada oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 14 Canada oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 15 Canada oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 16 Europe oligonucleotide synthesis market, by country, 2018 - 2030 (USD Million)
Table 17 Europe oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 18 Europe oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 19 Europe oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 20 UK oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 21 UK oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 22 UK oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 23 Germany oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 24 Germany oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 25 Germany oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 26 France oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 27 France oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 28 France oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 29 Italy oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 30 Italy oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 31 Italy oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 32 Spain oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 33 Spain oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 34 Spain oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 35 Denmark oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 36 Denmark oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 37 Denmark oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 38 Sweden oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 39 Sweden oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 40 Sweden oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 41 Norway oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 42 Norway oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 43 Norway oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 44 Asia Pacific oligonucleotide synthesis market, by country, 2018 - 2030 (USD Million)
Table 45 Asia Pacific oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 46 Asia Pacific oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 47 Asia Pacific oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 48 Japan oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 49 Japan oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 50 Japan oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 51 China oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 52 China oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 53 China oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 54 India oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 55 India oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 56 India oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 57 Australia oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 58 Australia oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 59 Australia oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 60 Thailand oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 61 Thailand oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 62 Thailand oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 63 South Korea oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 64 South Korea oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 65 South Korea oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 66 Latin America oligonucleotide synthesis market, by country, 2018 - 2030 (USD Million)
Table 67 Latin America oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 68 Latin America oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 69 Latin America oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 70 Brazil oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 71 Brazil oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 72 Brazil oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 73 Mexico oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 74 Mexico oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 75 Mexico oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 76 Argentina oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 77 Argentina oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 78 Argentina oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 79 Middle East & Africa oligonucleotide synthesis market, by country, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 83 South Africa oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 84 South Africa oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 85 South Africa oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 89 UAE oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 90 UAE oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 91 UAE oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
Table 92 Kuwait oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
Table 93 Kuwait oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
Table 94 Kuwait oligonucleotide synthesis market, by end user, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain-based sizing & forecasting
FIG. 6 Market formulation & validation
FIG. 7 single-cell omics market segmentation
FIG. 8 Market snapshot, 2022
FIG. 9 Market trends & outlook
FIG. 10 Market driver relevance analysis (current & future impact)
FIG. 11 Market restraint relevance analysis (current & future impact)
FIG. 12 PESTEL analysis
FIG. 13 Porter’s five forces analysis
FIG. 14 Global oligonucleotide synthesis market: Product movement analysis
FIG. 15 Global oligonucleotide synthesis market, for oligonucleotides, 2018 - 2030 (USD Million)
FIG. 16 Global column-based oligos market, 2018 - 2030 (USD Million)
FIG. 17 Global array-based oligos market, 2018 - 2030 (USD Million)
FIG. 18 Global DNA oligonucleotides market, 2018 - 2030 (USD Million)
FIG. 19 Global RNA oligonucleotides market, 2018 - 2030 (USD Million)
FIG. 20 Global oligonucleotide synthesis market, for equipment/synthesizer, 2018 - 2030 (USD Million)
FIG. 21 Global oligonucleotide synthesis market, for reagents, 2018 - 2030 (USD Million)
FIG. 22 Global oligonucleotide synthesis market, for services, 2018 - 2030 (USD Million)
FIG. 23 Global oligo synthesis market, 2018 - 2030 (USD Million)
FIG. 24 Global 25 nmol oligo synthesis market, 2018 - 2030 (USD Million)
FIG. 25 Global 50 nmol oligo synthesis market, 2018 - 2030 (USD Million)
FIG. 26 Global 200 nmol oligo synthesis market, 2018 - 2030 (USD Million)
FIG. 27 Global 1000 nmol oligo synthesis market, 2018 - 2030 (USD Million)
FIG. 28 Global 10,000 nmol oligo synthesis market, 2018 - 2030 (USD Million)
FIG. 29 Global purification market, 2018 - 2030 (USD Million)
FIG. 30 Global modification market, 2018 - 2030 (USD Million)
FIG. 31 Global oligonucleotide synthesis market: Application movement analysis
FIG. 32 Global oligonucleotide synthesis market, for PCR primers, 2018 - 2030 (USD Million)
FIG. 33 Global oligonucleotide synthesis market, for PCR assays and panels, 2018 - 2030 (USD Million)
FIG. 34 Global oligonucleotide synthesis market, for sequencing, 2018 - 2030 (USD Million)
FIG. 35 Global oligonucleotide synthesis market, for DNA Microarrays, 2018 - 2030 (USD Million)
FIG. 36 Global oligonucleotide synthesis market, for Fluorescence In Situ Hybridization (FISH), 2018 - 2030 (USD Million)
FIG. 37 Global oligonucleotide synthesis market, for antisense oligonucleotides, 2018 - 2030 (USD Million)
FIG. 38 Global oligonucleotide synthesis market, for other applications, 2018 - 2030 (USD Million)
FIG. 39 Global oligonucleotide synthesis market: End-user movement analysis
FIG. 40 Global oligonucleotide synthesis market, for academic and research institutes, 2018 - 2030 (USD Million)
FIG. 41 Global oligonucleotide synthesis market, for pharmaceutical & biotechnology companies, 2018 - 2030 (USD Million)
FIG. 42 Global oligonucleotide synthesis market, for diagnostic laboratories, 2018 - 2030 (USD Million)
FIG. 43 Regional marketplace: Key takeaways
FIG. 44 Regional outlook, 2022 & 2030
FIG. 45 Global oligonucleotide synthesis market: Region movement analysis
FIG. 46 North America oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 47 U.S. oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 48 Canada oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 49 Europe oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 50 Germany oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 51 UK oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 52 France oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 53 Italy oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 54 Spain oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 55 Denmark oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 56 Sweden oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 57 Norway oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 58 Asia Pacific oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 59 Japan oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 60 China oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 61 India oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 62 Australia oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 63 South Korea oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 64 Thailand oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 65 Latin America oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 66 Brazil oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 67 Mexico oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 68 Argentina oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 69 Middle East and Africa oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 70 South Africa oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 71 Saudi Arabia oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 72 UAE oligonucleotide synthesis market, 2018 - 2030 (USD Million)
FIG. 73 Kuwait oligonucleotide synthesis market, 2018 - 2030 (USD Million)

Companies Mentioned

  • Thermo Fisher Scientific, Inc.
  • Merck & Co. Inc
  • PerkinElmer Inc.
  • Agilent Technologies, Inc
  • Bio-synthesis, Inc.
  • Kaneka Eurogentec S.A
  • Integrated DNA Technologies, Inc.
  • BioAutomation (BIOSEARCH TECHNOLOGIES)
  • Biolegio
  • Twist Bioscience

Methodology

Loading
LOADING...

Related Topics

Related Reports

Oligonucleotide Synthesis Markets - Forecasts by Oligo Length, Application, and Product - With Executive and Consultant Guides. 2023 to 2027 - Product Image

Oligonucleotide Synthesis Markets - Forecasts by Oligo Length, Application, and Product - With Executive and Consultant Guides. 2023 to 2027

  • Report
  • 352 Pages
  • Global
From
Oligonucleotide Therapeutics - Global Strategic Business Report - Product Image

Oligonucleotide Therapeutics - Global Strategic Business Report

  • Report
  • 193 Pages
  • Global
From
Genomics - Global Strategic Business Report - Product Image

Genomics - Global Strategic Business Report

  • Report
  • 292 Pages
  • Global
From
Gene Therapy Market by Type (Gene silencing, Gene augmentation), Vector (Viral (Retroviral, AAV), Non-viral (Oligonucleotide)), Therapeutic Area (Neurology, Oncology), Delivery Method (In-vivo, Ex-vivo), RoA (Intravenous) & Region - Global Forecast to 2028 - Product Image

Gene Therapy Market by Type (Gene silencing, Gene augmentation), Vector (Viral (Retroviral, AAV), Non-viral (Oligonucleotide)), Therapeutic Area (Neurology, Oncology), Delivery Method (In-vivo, Ex-vivo), RoA (Intravenous) & Region - Global Forecast to 2028

  • Report
  • 276 Pages
  • Global
From
Global Oligonucleotide Synthesis Market by Product (Equipment, Linkers & Adaptor, Probes), Type (Custom, Pre-designed), Application, End-User - Forecast 2023-2030 - Product Image

Global Oligonucleotide Synthesis Market by Product (Equipment, Linkers & Adaptor, Probes), Type (Custom, Pre-designed), Application, End-User - Forecast 2023-2030

  • Report
  • 185 Pages
  • Global
From
Copyright © 2002-2023 Research and Markets. All Rights Reserved.